Webcasts: Solid Dosage Drugs

Webinar Date/Time: Thursday, October 12, 2023 at 11am EDT | 4pm BST | 5pm CEST

Webinar Date/Time: Thursday, September 21, 2023 at 11am ET | 10am CT | 8am PT | 4 pm BST

Webinar Date/Time: Thursday, April 20th, 2023 4:00pm GMT | 11:00 am EDT | 5:00 pm CEST

Webinar Date/Time: Tue, Apr 18, 2023 11:00 AM EDT

Webinar Date/Time: Session 1: Tuesday, February 28th , 2023 at 4pm GMT | 11am EDT | 5pm CEST Session 2: Wednesday, March 22nd, 2023 4:00pm GMT | 11:00 am EDT | 5:00 pm CEST Session 3: Thursday, April 20th, 2023 at 4 GMT | 11am EDT | 5pm CEST

Webinar Date/Time: Thu, Mar 23, 2023 11:00 AM EDT

Webinar Date/Time: Session 1: Evaluating the Best Formulations for Amorphous Solid Dispersions by Spray Drying: Tuesday, February 28th, 2023 4:00pm GMT | 11:00 am EDT | 5:00 pm CEST Session 2: ASDs by Spray Drying: Process Development & Scale-Up: Wednesday, March 22nd, 2023 at 4pm GMT | 11am EDT | 5pm CEST Session 3: Commercial Reality and Lifecycle Management of ASDs: Thursday, April 20th, 2023 at 4 GMT | 11am EDT | 5pm CEST

Webinar Date/Time: Thu, Oct 27, 2022 11:00 AM EDT

Webinar Date/Time: Tuesday, February 21st, 2023 at 11am EST | 8am PST | 4pm GMT | 5pm CET

Tuesday, October 4, 2022 at 11am CDT |12pm EDT | 9am PDT Is developing formulations of highly lipophilic compounds worth the effort? With today’s excipients and technologies, the answer is a definite yes. This presentation will showcase the issues presented by lipophilic compounds and ways to address them.

Thursday, September 28, 2022 at 11am ET | 10am CT | 8am PT Learn the key benefits of continuous OSD production as well as the importance of authenticating OSD products at the dose-level with experts from Syntegon and Colorcon in this episode of the PharmTech Drug Digest Video Series.

Thursday, September 8, 2022 at 11am EDT; 4pm GMT; 5pm CEST This webinar will highlight the new solubility enhancing Dispersome® technology, which is based on the amorphous stabilization of a given drug using the protein beta-lactoglobulin (BLG) as novel pharmaceutical excipient. Several relevant case studies are presented to showcase the potential of this new technology. Subsequently, the webinar provides a roadmap on how these formulations can be manufactured on a commercial scale. The webinar will also cover the manufacturing of the formulations.

Tuesday, June 14th, 2022 at 7:30am PDT | 9:30am CDT | 10:30am EDT Join Lonza and Quench Medical in a joint discussion about process engineering for the respiratory delivery of gemcitabine to treat lung cancer

April 27th, 2022 at 11am EDT | 8am PDT | 3pm GMT | 10am CDT Transform Data into Scientific Discoveries. PerkinElmer’s World Class eNotebook and Scitara DLX Live Demo! Signaling the Future with True Informatics Data Mobility. Watch our live demonstration on how to achieve true data mobility!

Wednesday March 2, 2022 at 11am EST | 4pm GMT | 5pm CET Compounds that are poorly soluble in water are still prevalent in the pharmaceutical industry drug development pipeline. Enabling technologies such as lipid-based formulations (LBF) and amorphous solid dispersions (ASDs) can address these bioavailability limitations, enabling the creation of effective drug products.

***Live: Thursday, January 28, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET*** Amorphous solid dispersions (ASDs) are a critical technology for bioavailability enhancement. In this webcast Lonza’s Deanna Mudie and Aaron Stewart discuss Lonza’s best practices for ASD formulation development and in vitro testing.*** On demand available after final airing until Jan. 28, 2022.***